AzTrials
AzTrials

Renal StoneNCT06131151

Comparison Between External Oblique Intercostal Block and Erector Spinae Plane Block in PCNL

A study testing External Oblique Intercostal Block and Erector Spinae Plane Block in people with Renal Stone, run by Assiut University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record

Search all trials

Trial summary

The aim of the study is to compare the post-operative analgesic effect of USG unilateral External oblique intercostal (EOI) block with Erector spinae plane block (ESPB) for after percutaneous Nephrolithotomy with a hypothesis that both External oblique intercostal fascial plane block and Erector spinae plane block are… Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Renal Stone
What is being tested?
External Oblique Intercostal Block and Erector Spinae Plane Block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteEgypt
Study dates
12 Jan 2024to 3 Jan 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age between 18 and 65 years Body mass index of 18-35 kg/m2 Patients with the American Society of Anesthesiologists physical status I/II Patients scheduled for elective Percutaneous Nephrolithotomy Both sexes, males and females

Who cannot join

  • Patients refusal Allergy to local anaesthetics Infection at the site of injection Coagulopathy Chronic pain syndrome Prolonged opioid medication Patients who received any analgesic 24 h befor surgery

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Faculty of Medicine, Assiut University

    Asyut, 71111

Other trials in Egypt

About this study

Official title: Comparison Between Analgesic Effect of Ultrasound Guided External Oblique Intercostal Block and Erector Spinae Plane Block in Patients Undergoing Percutaneous Nephrolithotomy.

The aim of the study is to compare the post-operative analgesic effect of USG unilateral External oblique intercostal (EOI) block with Erector spinae plane block (ESPB) for after percutaneous Nephrolithotomy with a hypothesis that both External oblique intercostal fascial plane block and Erector spinae plane block are effective in providing postoperative analgesia.

Read the detailed description

Introduction:

Percautaneous nephrolithotomy is the tretment of choice for patients with multiple or complex kidney or upper urinary tract stones. visceral pain from the kidney and ureter and somatic pain from the incision site are the primary cause of immediate postoperative pain following PCNL. poor pain control is associated with unwanted consequences such as patient discomfort, delayed recovery, and prolonged hospital stay.

This necessitates meticulous multi-modality analgesia due to mild to moderate pain originating from renal capsule dilatation or nephrostomy tube-related stress during the first 24 h after operation. Multimodal analgesia techniques are utilized broadly to manage postoperative pain. The concept of multimodal analgesia implies not only providing analgesic drugs, but also performing nerve blocks with local anaesthetics.

first described the Erector Spinae Plane Block (ESPB), the indications and clinical use of the block for different surgical interventions have been growing. Although ESPB is interfacial plane block, anatomical studies support the idea that some of its clinical benefit may derive from spread to the paravertebral and epidural space. External oblique intercostal (EOI) block is relatively new block technique modified aiming at obtaining upper midline and lateral abdominal wall analgesia. EOI block is achived by injecting the local anesthetic solution into the fascial plane on the deep aspect of the external oblique muscle. Previous studies have hypothesized that the block succesfully anesthetized the lateral cutaneous branch and the anterior cutaneous branch of the thoracoabdominal nerves, with low pain scores and minimal narcotic use postoperatively.

Recently, there have been several publications describing external oblique nerve blocks to control post-operativte pain after abdominal surgery.

Aim of the work:

The aim of this study is to compare the post-operative analgesic effect of USG unilateral External oblique intercostal (EOI) block with Erector spinae plane block (ESPB) for after Percutaneous Nephrolithotomy with a hypothesis that both External oblique intercostal fascial plane block and Erector spinae plane block are effective in providing postoperative analgesia.

Sample size calculation:

Based on the results of a previous study, a sample size of 21 patients in each group will be calculated to detect a 20% difference in the time to first analgesic request, with alfa=0.05 and a power of 85%. Twenty-seven patients in each group will be recruited to compensate for the dropouts.

Group A: will include 27 patients, will receive External Oblique Intercostal Block.

Group B: will include 27 patients, will receive Erector Spinae Plane Block. Randomization will be performed using an online random number generator. concealment was achieved using sealed opaque envelopes.

  1. Anesthesia induction:

Standard monitoring procedures will include pulse oximetry, electrocardiography, and noninvasive arterial pressure prior to anesthetic induction. All patients will be premedicated with intravenous (i.v.) midazolam 1-2 mg and antibiotic prophylaxis, according to the hospitals protocol. Anesthesia will be induced with intravenously (IV) adminestrated propofol. 2mg/kg, fentanyl 1mic/kg, and recuronium bromide 0.6 mg/kg following which endotracheal intubation will be performed. Anesthesia will be maintained with oxygen, air, and isoflurane using controlled ventilation with closed circuit in order to ensure normocarbia. At the end of the surgery, patients will receive their intervention according to gorup allocation under sterile conditions.

  1. Intervention:
  2. External Oblique Intercistal Block: A high frequency linear ultrasound probe will be placed in a longitudinal parasagital orientation in the anterior midaxillary line. A 21G 10 cm needle will be inserted using an in-plane approach. The tip of the needle will be placed into the fascial plane on the deep aspect of the external oblique muscle. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline. ) will be injected.
  3. Erector Spinae Plane block:

A high frequency linear ultrasound probe will be placed in a longitudinal parasagital orientation 2.5-3 cm lateral to the T9 spinous process. A 21G 10 cm needle will be inserted using an in-place approach. The tip of the needle will be placed into the fascial plane on the top of the aspect of the erector spinae muscle. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline. ) will be injected.

Peimary Outcome:

The first call for rescue analgesia.

Secondary Outcome:

  1. The total analgesic requirement in 24 hours.
  2. Any adverse effects related to anesthesia or the technique.
  3. Pain scores; Numerical Rating Scales (NRS) at rest and when coughing (at 1, 2, 4, 8, 16 and 24 hours postoperatively.)
  4. Block related complications during and after block procedure till 24 hours postoperatively (local anesthetic systemic toxicity, pneumothorax and vascular puncture during block procedure).

Statistical Analysis:

Continous data with normal distribution will be compared by paired or unpaired t-tests, whereas non-normally distributed data will be assessed using the Mann- Whitney U test and Wilcoxon ranksum test for unpaired and paired results, respectively. Chi-square test or fisher's exact test will measure the association between qualitative variables.

P-valve>0.05 will be considered statistically significant.

Conditions
Renal Stone
Being tested
External Oblique Intercostal Block, Erector Spinae Plane Block
Medical subject headings
Nephrolithiasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • External Oblique Intercostal BlockProcedure or surgery

    A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.

  • Erector Spinae Plane BlockProcedure or surgery

    A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.

Study groups in NCT06131151
Study groupRoleWhat they receive
External Oblique Intercostal BlockExperimental27 patients will receive External Oblique Intercostal Block. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.
Receives: Procedure: External Oblique Intercostal Block
Erector Spinae Plane BlockExperimental27 patients will receive Erector Spinae Plane Block. A volume of 20 ml of LA (20 ml of bupivacaine 0.375% plus 5 ug/ml adrenaline ) will be injected.
Receives: Procedure: Erector Spinae Plane Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The first call for rescue analgesia after the end of the surgery

    Measured: 24 hours

Secondary outcomes (1)
  1. pain scores; Numerical Rating Scale (NRS)

    Numerical Rating Scale at rest and when coughing. Zero is equivalent to no pain and 10 indicates the worst possible pain.

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2023
  2. Study start12 Jan 2024
  3. Primary completion3 Jan 2026
  4. Study completion3 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06131151
Sponsor's protocol ID
EOI Block
Status last verified
Sep 2026
First submitted
30 Oct 2023
Last updated
10 Sep 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in